Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.

The mechanism of clearance of circulating fibrin monomer was investigated in rabbits through (1) study of decay in plasma concentrations of 125I-labeled monomers with variant fibrinopeptide content and (2) concurrent analysis of decay of the monomers relative to coinjected 131I-fibrinogen. Under the conditions employed, essentially all of the fibrin became distributed in a soluble form in plasma and decayed independently of the coinjected fibrinogen. Among the species of fibrin studied, monomer lacking fibrinopeptide A alone (alpha-fibrin) underwent very rapid clearance by a saturable mechanism that was not evident in relatively sluggish clearance of monomer lacking either fibrinopeptide B alone (beta-fibrin) or both fibrinopeptides A and B (alpha beta-fibrin). Decay of alpha-fibrin conformed with a kinetic mechanism involving first-order permeation of the fibrin into extravascular space at a rate equivalent to that of permeation of fibrinogen; unlike fibrinogen, however, the alpha-fibrin underwent immediate absorption in parallel with permeation (t1/2 = 2.6 hours) at doses below an apparent saturating level of 3 mg/kg. At doses near the absorptive limit, the uptake accompanying permeation diminished as in a second-order kinetic mechanism, and at very high doses the plasma decay of the alpha-fibrin approached that of fibrinogen. The beta- and alpha beta-fibrins also permeated extravascular space in parallel with fibrinogen, but absorption proceeded sluggishly (t1/2 = 11 and 16 hours, respectively) at low doses and did not change with increasing dose. The uniquely rapid and saturable clearance of alpha-fibrin is suggested to involve uptake through the fibrin aggregation site that is blocked by fibrinopeptide A in fibrinogen and beta-fibrin and by tight binding to fibrinogen in soluble complexes formed by alpha beta-fibrin. A corollary of this hypothesis is that rapid uptake depends on dissociability of fibrin complexes for access to the aggregation site, a mechanism that is just the converse of uptake through aggregation.

[1]  J. Shainoff Analysis of composition of soluble fibrinogen/fibrin complexes by differential ultracentrifugation , 1985 .

[2]  J. Shainoff,et al.  FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE * , 1983, Annals of the New York Academy of Sciences.

[3]  F. Brosstad,et al.  SOLUBLE DES-AA FIBRIN CLEARANCE IN HEALTHY HUMAN SUBJECTS , 1982 .

[4]  L. Sherman,et al.  Fibronectin: blood turnover in normal animals and during intravascular coagulation. , 1982, Blood.

[5]  H. Nossel Relative proteolysis of the fibrinogen Bβ chain by thrombin and plasmin as a determinant of thrombosis , 1981, Nature.

[6]  G. Chisolm,et al.  Measurements of the degradation products of radioiodinated proteins. , 1981, Analytical biochemistry.

[7]  E. Engvall,et al.  Fibronectin: current concepts of its structure and functions. , 1980, Collagen and related research.

[8]  W. Krell,et al.  Studies on Circulating Soluble Fibrin: Separation of 125I‐Des‐AB Fibrin and 131I‐Fibrinogen by Gel Filtration , 1980, British journal of haematology.

[9]  J. Shainoff,et al.  Fibrinopeptide B and Aggregation of Fibrinogen , 1979, Thrombosis and Haemostasis.

[10]  B. Blombäck,et al.  A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.

[11]  A. Laudano,et al.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Williams Em,et al.  Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. , 1978 .

[13]  J. Kaplan,et al.  Low-grade intravascular coagulation and reticuloendothelial function. , 1978, The American journal of physiology.

[14]  Mosesson Mw Cold-insoluble globulin (CIg), a circulating cell surface protein. , 1977 .

[15]  L. Sherman,et al.  Quantitation of the Reticuloendothelial System Clearance of Soluble Fibrin , 1977, British journal of haematology.

[16]  L. Sherman,et al.  Specific binding of soluble fibrin to macrophages , 1977, The Journal of experimental medicine.

[17]  H. Kanaide,et al.  Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa). , 1976, The Journal of laboratory and clinical medicine.

[18]  L. Sherman,et al.  In vitro formation and i vivo clearance of fibrinogen: fibrin complexes. , 1975, The Journal of laboratory and clinical medicine.

[19]  V. Gurewich,et al.  The Organ Distribution of 125I‐Fibrin in the Generalized Shwartzman Reaction and its Relation to Leucocytes , 1974, British journal of haematology.

[20]  K. R. Woods,et al.  Evidence for localization of polymerization sites in fibrinogen. , 1974, The Journal of biological chemistry.

[21]  P. Kierulf Studies on soluble fibrin in plasma IV: Isolation and characterization of the clottable proteins obtained from thrombin incubated plasma upon gelation with ethanol , 1973 .

[22]  M. Welch,et al.  Studies of radioiodinated fibrinogen. I. Physicochemical properties of the ICl, chloramine-T, and electrolytic reaction products. , 1972, Biochimica et biophysica acta.

[23]  L. Sherman Fibrinogen turnover: demonstration of multiple pathways of catabolism. , 1972, The Journal of laboratory and clinical medicine.

[24]  J. Shainoff,et al.  Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. , 1970, The Journal of laboratory and clinical medicine.

[25]  Sam Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide BHerzig, R. H., Ratnoff, O. D., and Shainoff, J. R. (University Hospitals of Cleveland, Cleveland, Ohio). J. Lab. Clin. Med., 76, 451, 1970 , 1971 .

[26]  E. Regoeczi Fibrinogen catabolism: kinetics of catabolism following sudden elevation of the pool with exogenous fibrinogen. , 1970, Clinical science.

[27]  T. Saba,et al.  PROPERTIES OF THE OPSONIC SYSTEM REGULATING IN VITRO HEPATIC PHAGOCYTOSIS. , 1966 .

[28]  J. Finlayson,et al.  Heterogeneity of Human Fibrinogen , 1963 .